Ashwin Achuthaprasad
Neurology · Houston, TXNPI 1598541013
Payments from drug & device makers
Across 98 payments — averaging $24.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$390
- Genentech USA, Inc.$248
- UCB, Inc.$233
- AbbVie$207
- Acadia Pharmaceuticals Inc$172
- CSL Behring$158
- plus $967 from 11 others
What the payments were for
- Food & beverage$2,375100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $390 |
| Genentech USA, Inc. | 12 | $248 |
| UCB, Inc. | 7 | $233 |
| AbbVie | 10 | $207 |
| Acadia Pharmaceuticals Inc | 8 | $172 |
| CSL Behring | 7 | $158 |
| SK Life Science, Inc. | 2 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $138 |
| Argenx US, Inc. | 5 | $130 |
| AstraZeneca(2 entities) | 6 | $104 |
| Eisai Inc. | 3 | $102 |
| Springworks Therapeutics, Inc. | 3 | $73 |
| Amgen | 2 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Johnson & Johnson(2 entities) | 3 | $61 |
| Grifols USA, LLC | 3 | $59 |
| Amicus Therapeutics, Inc. | 1 | $20 |
How this compares
$2,375 in reported general payments places this provider in the 45th percentile of 1,246 neurology providers in Texas.
Other neurology in Houston
- Jamshid LotfiHouston$6M
- Nazanin MajdHouston$5.9M
- Aziz ShaibaniHouston$5.5M
- John LindseyHouston$3.9M
- Joseph KassHouston$3.7M
- William OndoHouston$3.1M
- Vinay PuduvalliHouston$2.5M
- Erin Furr-StimmingHouston$2.1M
- Arjun TarakadHouston$2M
- Mazen DimachkieHouston$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.